Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Other Non-Current Liabilities: 2016-2025

Historic Other Non-Current Liabilities for Collegium Pharmaceutical (COLL) over the last 4 years, with Sep 2025 value amounting to $19,000.

  • Collegium Pharmaceutical's Other Non-Current Liabilities fell 99.54% to $19,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $19,000, marking a year-over-year decrease of 99.54%. This contributed to the annual value of $1.2 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, Collegium Pharmaceutical's Other Non-Current Liabilities stood at $19,000, which was down 50.00% from $38,000 recorded in Q2 2025.
  • Collegium Pharmaceutical's Other Non-Current Liabilities' 5-year high stood at $4.1 million during Q3 2024, with a 5-year trough of $19,000 in Q3 2025.
  • For the 2-year period, Collegium Pharmaceutical's Other Non-Current Liabilities averaged around $1.1 million, with its median value being $396,000 (2025).
  • Data for Collegium Pharmaceutical's Other Non-Current Liabilities shows a maximum YoY slumped of 99.54% (in 2025) over the last 5 years.
  • Over the past 2 years, Collegium Pharmaceutical's Other Non-Current Liabilities (Quarterly) stood at $1.2 million in 2024, then crashed by 99.54% to $19,000 in 2025.
  • Its last three reported values are $19,000 in Q3 2025, $38,000 for Q2 2025, and $396,000 during Q1 2025.